Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: perifosine
Sponsor: University Health Network, Toronto
Collaborators: National Cancer Institute (NCI)